Role of CYP2E1 in deramciclane metabolism

Drug Metabolism and Disposition

Volumn 33, Issue 11, 2005, Pages 1717-1722

  Monostory, Katalin ^a,c   Köhalmy, Krisztina ^a   Hazai, Eszter ^a   Vereczkey, László ^a   Kóbori, László ^b  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c NONE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2E1; DERAMCICLANE FUMARATE; DIETHYLTHIOCARBAMATE; ISONIAZID;

ANIMAL CELL; ARTICLE; BIOTRANSFORMATION; CATALYSIS; CATALYST; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; GENE EXPRESSION; HYDROXYLATION; LIVER MICROSOME; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; BORNANES; CYTOCHROME P-450 CYP2E1; DITIOCARB; ENZYME INDUCTION; ISONIAZID; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SEROTONIN ANTAGONISTS; TIME FACTORS;

ANIMALIA;

EID: 27544446293     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.003772     Document Type: Article

References (20)

1. Berényi E, Blaskó G, Fekete M, and Nógrádi M (1990) EGYT-3886. Drugs Future 15:1174-1175.
2. Gacsályi I, Gyertyán I, Petöcz L, and Budai Z (1988) Psychopharmacology of a new anxiolytic agent EGYT-3886. Pharmacol Res Commun 20 (Suppl I):115-116.
3. Guengerich FP, Kim D-H, and Iwasaki M (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight suspects. Chem Res Toxicol 4:168-179.
4. Kobayashi S, Murray S, Watson D, Sesardic D, Davies DS, and Boobis AR (1989) The specificity of inhibition of debrisoquine 4-hydoxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochem Pharmacol 38:2795-2799.
5. Kovács I, Maksay G, and Simonyi M (1989) Inhibition of high-affinity synaptosomal uptake of γ-aminobutyric acid by a bicyclo-heptane derivative. Arzneim-Forsch/Drug Res 39:295-297.
6. Laine K, De Bruyn S, Björklund H, Rouru J, Hanninen J, Scheinin H, and Anttila M (2004) Effect of the novel anxiolytic drug deramciclane on cytochrome P450 2D6 activity as measured by desipramine pharmacokinetics. Eur J Clin Pharmacol 59:893-898.
7. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
8. Maurel P (1996) The CYP3A family, in Cytochromes P450: Metabolic and Toxicological Aspects (Ioannides C ed) pp 241-270, CRC Press, Boca Raton, FL.
9. Maurel P (1998) Drug metabolizing enzymes. Curr Opin Crit Care 4:213-218.
10. Miners JO, Smith KJ, Robson RA, McManus ME, Veronese ME, and Birkett DJ (1988) Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P450 dependent xenobiotic oxidations. Biochem Pharmacol 37:1137-1144.
11. Monostory K, Köhalmy K, Ludányi K, Czira G, Holly S, Ürmös I, Klebovich I, Vereczkey L, and Kóbori L (2005) Biotransformation of deramciclane in primary hepatocytes of rat, mouse, rabbit, dog, and human. Drug Metab Dispos 33:1708-1716.
12. Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, and Tsutsui M (1996) Specificity of substrates and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26:681-693.
13. Peter R, Böcker R, Beaune PH, Iwasaki M, Guengerich FP, and Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566-573.
14. Reinke LA and Moyer MJ (1985) p-Nitrophenol hydroxylation: a microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 13:548-552.
15. Rendic S and Di Carlo FJ (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metab Rev 29:413-580.
16. Roos PH, Golub-Ciosk B, Kallweit P, Kauczinski D, and Hanstein WG (1993) Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes. Biochem Pharmacol 45:2239-2250.
17. Ryan DE, Ramanathan L, Iida S, Thomas PE, Hanui M, Shively JE, Lieber CS, and Levin W (1985) Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. J Biol Chem 260:6385-6393.
18. Siess M-H, Leclerc J, Canivenc-Lavier M-C, Rat P, and Suschetet M (1995) Heterogenous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicol Appl Pharmacol 130:73-78.
19. Tamási V, Vereczkey L, Falus A, and Monostory K (2003) Some aspects of interindividual variations in the metabolism of xenobiotics. Inflamm Res 52:322-333.
20. van der Hoeven TA and Coon MJ (1974) Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. J Biol Chem 249:6302-6310.